Fenofibrate/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (New page: {{subpages}} ==Parent topics== {{r|antilipemic agent}} {{r|medication}} {{r|cholesterol}} {{r|triglyceride}} ==Subtopics== ==Other related topics==) |
No edit summary |
||
| Line 11: | Line 11: | ||
==Other related topics== | ==Other related topics== | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Apolipoprotein C-III}} | |||
{{r|Dyslipidemia}} | |||
{{r|Drug treatments for obesity}} | |||
Latest revision as of 06:00, 16 August 2024
- See also changes related to Fenofibrate, or pages that link to Fenofibrate or to this page or whose text contains "Fenofibrate".
Parent topics
- Antilipemic agent [r]: Medications for the treatment of hypercholesterolemia and hypertriglyceridemia. [e]
- Medication [r]: A licensed drug taken to cure or reduce symptoms of an illness or medical condition. [e]
- Cholesterol [r]: Principal sterol of all higher animals. [e]
- Triglyceride [r]: Add brief definition or description
Subtopics
- Apolipoprotein C-III [r]: A 9-kDa protein component of very-low-density lipoproteins and chylomicron remnants, synthesized in the liver, that is an inhibitor of lipoprotein lipase [e]
- Dyslipidemia [r]: Abnormal lipid serum levels, such as high total cholesterol or triglycerides, low HDL or high LDL cholesterol. [e]
- Drug treatments for obesity [r]: Treatments of obesity that are based on drugs. [e]